Abstract:Population-scale resources of genetic, molecular, and cellular information form the basis for understanding human genomes, charting the heritable basis of disease, and tracing the effects of mutations. Pooled perturbation assays applied to cellular models, probing the effect of many perturbations coupled with an scRNA-seq readout (Perturb-seq), are especially potent references for interpreting disease-linked mutations or gene expression changes. However, the utility of existing maps has been limited by the comprehensiveness of perturbations possible, and the relevance of their cell line context. Here, we present the first genome-scale CRISPR interference (CRISPRi) perturbation map with single-cell RNA sequencing readout across many human genetic backgrounds in human pluripotent cells. To do so, we establish large-scale CRISPRi screening in human induced pluripotent stem cells from healthy donors, using over 20,000 guide RNAs to target 7,226 genes across 34 cell lines from 26 genetic backgrounds, and gather expression data from nearly 2 million cells. We comprehensively map trans expression changes induced by the target knockdowns, which complement co-expression patterns in unperturbed cells and facilitate the functional annotation of target genes to biological processes and complexes. Consistency of targeting protein complex members point to protein complexes as a nexus for aggregating transcriptional variation, revealing novel interaction partners. We characterise variation in perturbation effects across donors, with expression quantitative trait loci linked to higher genetic modulation of perturbation effects but overall low replication of trans effects due to knockdown of their corresponding cis regulators. This study pioneers population-scale CRISPR perturbations with single cell readouts that will fuel foundation models for the future of effective modulation of cellular disease phenotypes.

Parallel genome-scale CRISPR screens distinguish pluripotency and self-renewal

Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness

Deconstructing Transcriptional Heterogeneity in Pluripotent Stem Cells

A Genome-Wide CRISPR Screen Identifies Factors Regulating Pluripotency Exit in Mouse Embryonic Stem Cells

A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs

Genome-wide gain-of-function screen identifies novel regulators of pluripotency.

Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency

A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity

Genome-Wide CRISPR Screen Identifies Puf60 As a Novel Stemness Gene of Mouse Embryonic Stem Cells

A CRISPR/Cas9 screen in embryonic stem cells reveals that Mdm2 regulates totipotency exit

Use of genome-wide RNAi screens to identify regulators of embryonic stem cell pluripotency and self-renewal.

Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations

A genome-scale single cell CRISPRi map of trans gene regulation across human pluripotent stem cell lines

Complex regulatory networks influence pluripotent cell state transitions in human iPSCs

A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal.

Dual genome-wide coding and lncRNA screens in neural induction of induced pluripotent stem cells

A PERTURBATION CELL ATLAS OF HUMAN INDUCED PLURIPOTENT STEM CELLS

Locus-Specific Isolation of the Nanog Chromatin Identifies Regulators Relevant to Pluripotency of Mouse Embryonic Stem Cells and Reprogramming of Somatic Cells

Mapping germ-layer specification preventing genes in hPSCs via genome-scale CRISPR screening

A CRISPR/Cas9-based Kinome Screen Identifies ErbB Signaling As a New Regulator of Human Naïve Pluripotency and Totipotency

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells